Contrast media
In 1993, the world market for contrast media was already estimated to be worth $ 3 billion.
In 2001, an astonishing 12.2 million contrast medium-supported CT studies were carried out in Europe alone. Currently, the overall sales of contrast media are estimated to rise to $915 million in Europe in 2008.
In its brief history, two major developments occurred:
A switch from hyper- to low-osmolar iodinated agents (late 80s), after costs on the latter dropped
The widespread introduction of MRI contrast agents (90s), which largely accounts for the reduced market share of iodinated contrast media sales, from 91.7% in 1992 (world; non-ionic agents) to 60.7% est. (Europe) in 2008.
While many more compounds have been approved since – for use in the various imaging modalities – with the exception of the advent of ultrasound agents in Europe (1991) these are largely for use in specialist or research applications, e.g. intra-vascular (blood-pool) or tissue-specific (targeted) imaging.
This article was published on 05/01/2007
Search
Service
Company News
Technical infrastructure for EU funded R-bay project
Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.
Accu-Chek® Combo – put effective diabetes management into action
At the annual congress of the European Association for the Study of Diabetes (EASD) this year in Rome, Roche Diabetes Care introduced Accu-Chek Combo – the insulin pump system that combines an insulin pump with an intelligent glucose monitoring system, a bolus calculator, and an integrated pump remote-control.
Products redesigned to help patients simplify life with diabetes
Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.
